单身经济(共25份)
单身经济
-
艾媒咨询 | 2024年中国母婴市场发展状况与消费者调研报告
受三孩政策驱动,中国生育率有望得到提升,政策及相关配套措施落地将带动母婴消费新增量。全球新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询)最新发布的《2024年中国母婴市场发展状况与消费者调研报告》数据显示,中国母婴行业市场规模逐年稳步增长,2023年达66478亿元,预计2027年将达到89149亿元,呈现显著的上升趋势。
Driven by the three-child policy, China's fertility rate is expected to be increased, and the landing of policies and related supporting measures will drive new increases in maternal and infant market. According to the latest "China Maternal and Infant Market Development and Consumer Research Report in 2024" released by iiMedia Research, a third-party data mining and analysis institution in the global new economy industry, the market size of China's maternal and infant industry has grown steadily year by year, reaching 6,647.8 billion yuan in 2023. It is expected to reach 8914.9 billion yuan in 2027, showing a significant upward trend. -
艾媒咨询|2024-2025年中国头皮疗养行业发展趋势分析报告
随着现代生活节奏加快、压力增大,头皮问题逐渐增多,消费者对于头皮疗养产品的需求日益增长。全球新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询)最新发布的《2024-2025年中国头皮疗养行业发展趋势分析报告》数据显示,2023年中国护发产品市场规模达到620.90亿元,同比增长3.4%,预计2025年将达691.07亿元。随着居民对头皮健康问题的日益重视,头皮疗养行业有望得到新的发展。
With the acceleration of the pace of modern life and the increase of pressure, scalp problems are gradually increasing, and the demand of consumers for scalp therapy products is growing. According to the latest "Analysis report on the development trend of China's scalp therapy industry from 2024 to 2025" released by iiMedia Research, a third-party data mining and analysis institution in the global new economy industry, the market size of China's hair care products will reach 62.09 billion yuan in 2023, an increase of 3.4%. It is expected to reach 69.11 billion yuan by 2025. With the increasing attention of residents to scalp health problems, scalp therapy industry is expected to get new development. -
艾媒咨询|2022年中国幽门螺旋杆菌检测市场专题调查报告
美国将幽门螺杆菌被列为明确致癌物后,幽门螺杆菌在中国受到了极大的关注。iiMedia Research(艾媒咨询)数据显示,2021年中国幽门螺杆菌检测市场规模73.1亿元,预计2022年将达到86.6亿元。艾媒咨询分析师认为,随着大众的健康意识逐渐加强,幽门螺杆菌自测产品将成为必需品,幽门螺杆菌检测市场发展空间广阔。而幽门螺杆菌自测产品的上市,有助于推动居家检测。(《艾媒咨询|2022年中国幽门螺旋杆菌检测市场专题调查报告》完整高清PDF版共23页,可点击文章底部报告下载按钮进行报告下载)
After the United States Department of Health & Human Services listed Helicobacter pylori as a definitive carcinogen, Helicobacter pylori received great attention in China. According to data from iiMedia Research, the market size of Helicobacter pylori testing in China will be 7.31 billion yuan in 2021 and is expected to reach 8.66 billion yuan in 2022. With increasing health awareness, Helicobacter pylori self-test product is necessary for people. The market for Helicobacter pylori self-test product is vast. The launch of Helicobacter pylori self-test products helps to promote home testing.(“iiMedia Report |Investigation Report on The Market of Helicobacter Pylori Testing in China in 2022”full version has 23 pages, please click the Browse HD Report button on the right side of the article to browse the report) -
艾媒咨询|2021年3-4月中国母婴行业月度运行数据监测报告
本报告研究涉及企业/品牌/案例:贝康医疗,锦欣生殖,美吉姆,红黄蓝
在人口老龄化加速发展的背景下,我国的生育政策保持利好。但是受到晚婚晚育及二孩大龄母亲等影响,辅助生育产业得到高速发展,2020年的市场规模达到354.73亿元。同时,婴儿早教行业在疫情后回复发展,iiMedia Research(艾媒咨询)数据显示,2021年,中国家长在挑选早教课程的考虑因素中,最重要的是早教内容的专业度和丰富度,占比分别高达64.1%和63.3%。
In the context of the accelerated development of population production, the birth policy has been maintained well. At the same time, early childhood education is affected by marriage and parenting and older mothers with two children, and the assisted reproductive industry has been developed. The market size in 2020 will reach 354.73. At the same time, the infant early education industry has resumed development after the epidemic was revealed. According to data from iiMedia Research, in 2021, among the factors that Chinese parents consider when choosing early education courses, the most important factor is the professionalism and degree of early education content, which will eventually be as high as 64.1% and 63.3%. -
艾媒咨询|2021年中国月饼市场与消费趋势调查报告
本报告研究涉及企业/品牌/案例:广州酒家,华美食品,苏州稻香村
数据显示,2020年中国月饼市场销售规模已超200亿元,随着疫情防控常态化、国民对传统节日重视提高,走亲访友的需求将继续复苏,预计2021年中国月饼销售规模将达218亿元。在行业快速发展的同时,市场消费也呈现出新的特点,2021年中国月饼消费自吃需求增多、送礼需求相对降低,保证月饼味道与品质,将成为月饼品牌持续发展的立足之本。从月饼制作企业来看,主要有餐饮企业布局食品生产业务、烘焙企业推出应季产品与以借势营销为主要目的的跨界品牌三种企业。总体而言,在市场竞争加剧、月饼消费需求变化等因素推动下,中国月饼市场将会朝着规范化、口味持续创新、包装风格本土化等方向发展。
According to data, the sales scale of China's mooncake market in 2020 has exceeded 20 billion yuan. With the normalization of epidemic prevention and control and the masses' emphasis on traditional festivals, the demand for visiting relatives and friends will continue to recover. It is estimated that the sales scale of mooncakes in China will reach 20 billion yuan in 2021. 21.8 billion yuan. With the rapid development of the industry, market consumption has also shown new characteristics. In 2021, the demand for self-catering mooncakes in my country will increase, and the demand for gifts will relatively decrease. Ensuring the taste and quality of mooncakes will become the basis for the sustainable development of mooncake brands. From the perspective of moon cake manufacturers, there are three main types of companies: catering companies that deploy food production business, bakery companies that launch seasonal products, and cross-border brands that focus on the market. In general, driven by factors such as intensified market competition and changes in moon cake consumer demand, the Chinese moon cake market will develop in the direction of standardization, continuous innovation in taste, and localization of packaging styles. -
艾媒咨询|2020年中国细胞生物产业和商业应用分析报告
本报告研究涉及企业/品牌/案例:华夏源、复星医药。
中国细胞生物产业类型呈现多样化趋势,细胞生物临床研究不断深化,伴随生态合作的拓展将进一步加速细胞生物产业生态圈的形成,生态圈的完善将在很大限度上推动产业快速发展。数据显示,中国细胞治疗企业融资金额不断增加,从2014年的0.2亿元增长至2019年的28.9亿元。其中,2018年中国细胞治疗企业融资额同比增长706.8%,呈现迅猛发展态势。未来中国细胞生物产业的发展将充满机遇,同时也有挑战并存。后续产业的发展,将在5G、人工智能等新技术应用下加速升级。面临多端变化的市场格局,企业也应积极开展生态合作以及更为密切关注市场需求动向,将疗法和新一代医疗创新技术深度融合,实现市场产品多元化与差异化,并推出独特性的精准治疗,从而最大限度地释放产业价值。
The types of cell biological industry in China show a trend of diversification, and the deepening of cell biological clinical research will further accelerate the formation of the cell biological industry ecosystem with the expansion of ecological cooperation, and the improvement of the ecosystem will promote the rapid development of the industry to a large extent. Data show that the financing amount of Chinese cell therapy enterprises keeps increasing, from 20 million yuan in 2014 to 2.89 billion yuan in 2019. Among them, in 2018, the financing amount of Chinese cell therapy enterprises increased by 706.8% year on year, showing a rapid development trend. In the future, the development of China's cell biology industry will be full of opportunities and challenges. The development of subsequent industries will be accelerated with the application of new technologies such as 5G and ARTIFICIAL intelligence. In the face of the changing market pattern, enterprises should also actively carry out ecological cooperation and pay close attention to the trend of market demand, deeply integrate therapy and new-generation medical innovation technology, realize the diversification and differentiation of market products, and launch unique precision therapy, so as to maximize the release of industrial value. -
艾媒报告|2020年中国医用防护物资产业运行、监管及机遇分析报告
2020年4月5日,全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020年中国医用防护物资产业运行、监管及机遇分析报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据,对2020年中国医用防护物资及其细分领域进行分析。特别针对2020年3月商务部等联合发布的《关于有序开展医疗物资出口的公告(2020年第5号)》新规定,对2020-2021年的中国医疗物资行业的发展趋势进行分析预判。截至北京时间2020年4月3日10时,全球共累计确诊1010702人。口罩、防护服等医疗防护用品已成为全球紧缺的必需品,但应注意疫情过去之后医疗防护用品可能面临产能过剩等问题,如何平衡行业产能是相关企业需要考虑的问题。
Medical protective equipment is a global necessity during the epidemic. This has become a new opportunity for Chinese companies and brands to go overseas. However, we must pay attention to the quality control of Chinese brands. In the future, branding and specialization will become the core competitiveness of domestic medical protective equipment manufacturers. . -
艾媒报告|2019年12月-2020年1月中国医疗器械行业运行及上市公司双月度报告
本报告研究涉及企业/品牌包括:Mavidon,Titan Medical,Aspire Capital Fund,CentriMag,汇桥资本集团,联影医疗技术集团,医达极星,大博医疗,安捷伦,润扬医疗器械,迈瑞医疗,乐普医疗,威高医用,华大基因,安图生物,健帆生物,鱼跃医疗,京东方科技,美亚光电,东软集团,祥生医疗,硕世生物,佰仁医疗,爱博诺德,伟思医疗,安必平,林华医疗,拱东医疗,天智航,三友医疗,赛科希德等。
截至 2020 年 1 月 31 日 24:00,国家卫生健康委员会公布全国确诊病例 11791 例,重症病例 1795 例。短期来看,预计疫情将继续持续一段时间。肺炎疫情期间,病毒检测带动试剂盒需求增加;病毒治疗带动医用设备及医用耗材需求增加。部分医疗器械企业有望构成业绩增厚。
As of 24:00 on January 31, 2020, the National Health Commission announced 11791 confirmed cases and 1795 severe cases. In the short term, the outbreak is expected to continue for some time. During the pneumonia epidemic, virus detection drives demand for kits; virus treatment drives demand for medical equipment and supplies. Some medical device companies are expected to increase their performance.
- 1
- 2
- 3
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告